Skip to content

3CDN

Content Daily News

3CDN
  • News
  • Business
  • Entertainment
  • General
  • Health
  • Science
  • Sports
  • Technology

GLP-1

Scientists Say They've Figured Out a Way to Reprogram the Pancreas to Produce GLP-1s Without Ozempic - Futurism

Scientists Develop Gene Therapy to Reprogram Pancreas for Continuous GLP-1 Production

Scientists develop a gene therapy to make the pancreas produce continuous GLP-1, offering a potential single-dose alternative to drugs like Ozempic. Read the full analysis.
Pfizer wins $10bn bidding war for weight-loss start-up Metsera - Financial Times

Pfizer Secures $10 Billion Weight-Loss Startup Metsera, Intensifying GLP-1 Race

Pfizer wins a $10 billion bidding war for weight-loss startup Metsera, securing a pipeline of next-generation oral GLP-1 agonists. Analysis of the strategic move and market impact.
Taking GLP-1s to Get Ahead at Work - The Cut

GLP-1 Drugs Enter the Boardroom: Professionals Use Ozempic for Career Advancement

Professionals are using GLP-1 drugs like Ozempic for cosmetic weight loss, viewing thinness as a career advantage. Analyze the trend, ethics, and workplace bias.
  • About Us
  • FAQ
  • Editorial Principles
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Sitemap
© 2025 3CDN Content Delivery News. All rights reserved.